$NGTF
NightFood Holdings, Inc. Stock $ngtf

$ngtf Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024053334 Filed on June 17, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2
Revenue		$1.352K	$29.51K
YoY Change		-87.25%	-75.92%
Cost Of Revenue		$2.030K	$53.69K
YoY Change		-96.53%	-57.53%
Gross Profit		-$680.00	-$24.18K
YoY Change		-98.58%	523.2%
Gross Profit Margin		-50.3%	-81.94%
Selling, General & Admin		$162.0K	$404.8K
YoY Change		4.48%	44.62%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$291.5K	$404.8K
YoY Change		87.26%	44.62%
Operating Profit		-$290.1K	-$429.0K
YoY Change		100.02%	51.16%
Interest Expense		-$86.14K	-$400.1K
YoY Change		-105.2%	60.78%
% of Operating Profit
Other Income/Expense, Net		-$379.6K	-$103.6K
YoY Change		-133.56%	-279.49%
Pretax Income		-$669.7K	-$974.2K
YoY Change		-167.93%	105.14%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$669.7K	-$990.7K
YoY Change		-167.93%	108.6%
Net Earnings / Revenue		-49535.43%	-3357.1%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share		-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	127.9M shares	127.9M shares	120.6M shares
Diluted Shares Outstanding		127.7M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$186.1K	$44.19K
YoY Change		597.94%	-84.27%
Cash & Equivalents	$148.3K	$186.1K	$44.19K
Short-Term Investments
Other Short-Term Assets	$107.2K	$187.2K	$92.73K
YoY Change	15.57%	101.59%	-32.71%
Inventory	$25.81K	$35.84K	$276.2K
Prepaid Expenses	$1.206K	$5.978K
Receivables	$22.34K	$25.66K	$33.40K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$303.6K	$434.8K	$446.5K
YoY Change	-32.01%	-23.54%	-47.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$868.7K	$1.333M
YoY Change
Intangibles	$897.5K	$1.333M	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets		$302.0K
YoY Change
Total Long-Term Assets	$1.339M	$1.635M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$303.6K	$434.8K	$446.5K
Total Long-Term Assets	$1.339M	$1.635M	$0.00
Total Assets	$1.643M	$2.070M	$446.5K
YoY Change	267.88%	264.01%	-47.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$624.7K	$648.7K	$563.7K
YoY Change	10.82%	21.58%	140.76%
Accrued Expenses		$234.4K
YoY Change		164.33%
Deferred Revenue
YoY Change
Short-Term Debt		$2.990M	$1.492M
YoY Change		249.69%	333.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.798M	$4.124M	$2.198M
YoY Change	118.27%	179.15%	280.1%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities			$0.00
YoY Change
Total Long-Term Liabilities		$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.798M	$4.124M	$2.198M
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities		$4.124M	$2.198M
YoY Change		179.15%	280.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.63M	-$37.65M	-$34.99M
YoY Change	10.4%	10.75%	24.51%
Common Stock	$128.9K	$127.9K	$123.6K
YoY Change	4.3%	12.15%	34.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.433M	-$2.054M	-$1.752M
YoY Change
Total Liabilities & Shareholders Equity	$1.643M	$2.070M	$446.5K
YoY Change	267.88%	264.01%	-47.09%

Cashflow Statement

Concept	2024 Q1	2023 Q2
OPERATING ACTIVITIES
Net Income	-$669.7K	-$990.7K
YoY Change	-167.93%	108.6%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$109.4K	-$217.5K
YoY Change	-57.51%	-36.23%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$326.0K	$0.00
YoY Change
Cash From Investing Activities	-$326.0K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	615.7K	235.1K
YoY Change	161.86%	135.11%
NET CHANGE
Cash From Operating Activities	-109.4K	-217.5K
Cash From Investing Activities	-326.0K	0.000
Cash From Financing Activities	615.7K	235.1K
Net Change In Cash	180.3K	17.52K
YoY Change	-906.94%	-107.26%
FREE CASH FLOW
Cash From Operating Activities	-$109.4K	-$217.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.021
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105672769	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126540836	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127688758	shares
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.006
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55406
	dei	Entity Registrant Name EntityRegistrantName	NIGHTFOOD HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3885019
	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 White Plains Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	888-6444
	dei	Security12b Title Security12bTitle	N/A
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127907407	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186072	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25657	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33396	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	35842	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	187225	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	434796	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	446511	usd
CY2024Q1	ngtf	Acquisition Costs Secured By Promissory Note AcquisitionCostsSecuredByPromissoryNote	302000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1333271	usd
CY2024Q1	us-gaap	Assets Assets	2070067	usd
CY2023Q2	us-gaap	Assets Assets	446511	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	883116	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2990249	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1491719	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4124112	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2198111	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127907407	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127907407	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123587968	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123587968	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	127907	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	123588	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35469552	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33112935	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37651522	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34988126	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2054045	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2070067	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446511	usd
CY2024Q1	us-gaap	Revenues Revenues	1352	usd
CY2023Q1	us-gaap	Revenues Revenues	10605	usd
	us-gaap	Revenues Revenues	10423	usd
	us-gaap	Revenues Revenues	103944	usd
CY2024Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2034	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	58474	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	60610	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	225591	usd
CY2024Q1	ngtf	Advertising And Promotional AdvertisingAndPromotional	6453	usd
CY2023Q1	ngtf	Advertising And Promotional AdvertisingAndPromotional	38960	usd
	ngtf	Advertising And Promotional AdvertisingAndPromotional	6044	usd
	ngtf	Advertising And Promotional AdvertisingAndPromotional	129295	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	162022	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	155076	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	375470	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	385711	usd
CY2024Q1	ngtf	Professional Fee ProfessionalFee	120983	usd
CY2023Q1	ngtf	Professional Fee ProfessionalFee	-96850	usd
	ngtf	Professional Fee ProfessionalFee	458299	usd
	ngtf	Professional Fee ProfessionalFee	744547	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	291492	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	155660	usd
	us-gaap	Operating Expenses OperatingExpenses	900423	usd
	us-gaap	Operating Expenses OperatingExpenses	1485144	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-290140	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-145055	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-890000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1381200	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	86136	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	40758	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	192872	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	98086	usd
CY2023Q1	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	-1696970	usd
	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	804160	usd
	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost	1813940	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	165113	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	132805	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	578853	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1162257	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128330	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-392459	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128330	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-319995	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-379579	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1130948	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1704215	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3394278	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-669719	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	985893	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2594215	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4775478	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	48410	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-2565151	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	69181	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1120514	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-718129	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3551044	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2663396	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5895993	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.006
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.021
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127688758	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105672769	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126540836	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98556215	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023Q3	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	50000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	84230	usd
CY2023Q3	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissued Associatedwith Promissorynotes AdjustmentstoadditionalpaidincapitalWarrantsissuedAssociatedwithPromissorynotes	9878	usd
CY2023Q3	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	699350	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1433042	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2341184	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7800	usd
CY2023Q4	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	22120	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-491454	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	127475	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	48676	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-449180	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-995623	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2802718	usd
CY2024Q1	ngtf	Stock Issued During Period Value Business Acquisition StockIssuedDuringPeriodValueBusinessAcquisition	1304437	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	113955	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-669719	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2054045	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20010	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	290070	usd
CY2022Q3	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	65783	usd
CY2022Q3	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	108126	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1201110	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-451545	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	224615	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16000	usd
CY2022Q4	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	60000	usd
CY2022Q4	ngtf	Stock Isuued Vested Warrants For Services StockIsuuedVestedWarrantsForServices	5250	usd
CY2022Q4	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	305829	usd
CY2022Q4	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	1220790	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-4560262	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3179323	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8000	usd
CY2023Q1	ngtf	Stock Isuued Vested Warrants For Services StockIsuuedVestedWarrantsForServices	7425	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5114	usd
CY2023Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	138566	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25100	usd
CY2023Q1	ngtf	Common Stock Issued Under Forbearance And Exchange Agreement CommonStockIssuedUnderForbearanceAndExchangeAgreement	342000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	765127	usd
CY2023Q1	ngtf	Warrants Issued As Financing Cost Associated With Convertible Notes WarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	239970	usd
CY2023Q1	ngtf	Warrants Issued As Financing Cost Under Common Stock Purchase Warrant WarrantsIssuedAsFinancingCostUnderCommonStockPurchaseWarrant	231430	usd
CY2023Q1	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	-250936	usd
CY2023Q1	ngtf	Adjustmentstoadditionalpaidincapital Warrantsissuedasfinancingcost AdjustmentstoadditionalpaidincapitalWarrantsissuedasfinancingcost	-227036	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	985893	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-908669	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2594215	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4775478	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	84230	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	12675	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Cost WarrantsAndReturnableWarrantsIssuedForFinancingCost	721470	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Cost WarrantsAndReturnableWarrantsIssuedForFinancingCost	482500	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7800	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	69110	usd
	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	50000	usd
	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	60000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	578853	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1162257	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-128330	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-319995	usd
	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments	-853053	usd
	ngtf	Consulting Fee Due To Conversion Price Adjustments ConsultingFeeDueToConversionPriceAdjustments	163019	usd
	ngtf	Financing Cost Due To Default FinancingCostDueToDefault	229468	usd
	us-gaap	Inventory Write Down InventoryWriteDown	251010	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	46130	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7738	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-40043	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	149990	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10650	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	63990	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	140628	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-44921	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	293277	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	358128	usd
	ngtf	Acquisition Costs Secured By Promissory Notes AcquisitionCostsSecuredByPromissoryNotes	176000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-325990	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	229719	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	138566	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	40000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	917055	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1443750	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1110628	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	917055	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	741407	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	141885	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-254216	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186072	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26661	usd
	us-gaap	Interest Paid Net InterestPaidNet	39452	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts	721470	usd
	us-gaap	Stock Issued1 StockIssued1	50000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	686	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	6550	usd
	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	69181	usd
	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	1055197	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	171711	usd
	ngtf	Preferred Stock C Issued Per Acquisition PreferredStockCIssuedPerAcquisition	868708	usd
	ngtf	Preferred Stock A Valuation Per Acquisition PreferredStockAValuationPerAcquisition	435729	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	113955	usd
	ngtf	Principal Increased Under Convertible Note Amended PrincipalIncreasedUnderConvertibleNoteAmended	12500	usd
	ngtf	Granted Interest Increased Under Convertible Note Amended GrantedInterestIncreasedUnderConvertibleNoteAmended	1875	usd
	ngtf	Acquisition Cost Under Promissory Note Acquired Under Business Acquisition AcquisitionCostUnderPromissoryNoteAcquiredUnderBusinessAcquisition	126000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>1. Description of Business and Going Concern </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Nightfood Holdings, Inc. (“we”, “us”, “the Company” or “Nightfood”) is a Nevada corporation incorporated on -October 16, 2013, to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. For the reporting period, all of our operations were being conducted through subsidiary Nightfood, Inc. We are also the sole shareholder of MJ Munchies, Inc., currently revoked in the State of Nevada, which owns certain intellectual property, but does not have any operations as of the period covered by these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On February 2, 2024, the Company closed the acquisition of Future Hospitality Ventures Holdings Inc. (“FHVH” or “Future Hospitality”), a Nevada corporation and a new entrant in the Robots-as-a-Service (RaaS) space from Mr. Lei Sonny Wang, who concurrently became the Chief Executive Officer (“CEO”) of Nightfood and a member of the Company’s board of directors. Under the leadership of Mr. Wang, Future Hospitality has secured distribution agreements with industry-leading manufacturers United Robotics Group Americas, Inc. and Botin Innovations, Inc. and is in the process of negotiating several additional supply opportunities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="background-color: white">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 866-291-7778. We maintain web sites at www.nightfood.com, </span>www.RoboOp365.com<span style="background-color: white">, along with several additional web properties. Any information that may appear on those web sites should not be deemed to be a part of this report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company’s fiscal year end is June 30.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statements are prepared using generally accepted accounting principles, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. No certainty of continuation can be stated.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the nine months ended March 31, 2024, the Company had an operating and net loss of $2,572,165, cash flow used in operations of $449,180 and an accumulated deficit of $37,629,472.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has limited available cash resources and we do not believe our cash on hand will be sufficient to fund our operations and growth throughout calendar year 2024 or adequate to satisfy our immediate or ongoing working capital needs. We are currently in default with respect to the terms of several of our convertible notes payable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is continuing to seek to raise capital through the sales of its common stock, preferred stock and/or convertible notes, as well as potentially the exercise of outstanding warrants, to finance the Company’s operations, of which it can give no assurance of success. Management has devoted a significant amount of time to the raising of capital from additional debt and equity financing. However, the Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. Additionally, management is investing in the acquisition of additional revenue generating assets through the issuance of debt and/or equity to further assist the Company’s growth initiatives. As of March 31, 2024 we have advanced proceeds totaling $302,000 to potential targets, which are under negotiation for acquisition as soon as practicable subsequent to June 30, 2024.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the Company has limited sales, no certainty of continuation can be stated. The Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. In addition, the Company will receive the proceeds from its outstanding warrants as, if and when such warrants are exercised for cash. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even if the Company is successful in raising additional funds, the Company cannot give any assurance that it will, in the future, be able to achieve a level of profitability from the sale of the products and services of its subsidiaries to sustain operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></td></tr> </table>
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-449180	usd
CY2024Q1	ngtf	Acquisition Costs Secured By Promissory Note AcquisitionCostsSecuredByPromissoryNote	302000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Use of Estimates</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</span></td></tr> </table>
	ngtf	Shares Of Common Stock Exchanged For Returnable Warrants SharesOfCommonStockExchangedForReturnableWarrants	10869566	shares
CY2024Q1	ngtf	Common Stock Returnable Warrants CommonStockReturnableWarrants	342000	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1051801	shares
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	1988402	usd
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	105455	usd
	us-gaap	Inventory Write Down InventoryWriteDown	251010	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6044	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	129295	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Concentration of Credit Risk</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At March 31, 2024 and June 30, 2023, the Company did not have any uninsured cash deposits.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Deemed Dividend – Series B Preferred Stock Warrants :</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each share of the Company’s Series B Preferred Stock, par value $0.001 per share (the “B Preferred” or “B Preferred Stock”) has a liquidation preference of $1,000 and has no voting rights except as to matters pertaining to the rights and privileges of the B Preferred. Each share of B Preferred is convertible at the option of the holder thereof into (i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.11082 per share through March 31, 2024. The exercise price of these warrants can continue to adjust as the result of subsequent financing events and stock transactions. These adjustments can result in an exercise price that is either higher, or lower, than the price as of March 31, 2024.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The value of the deemed dividend was approximately $4.4 million as of June 30, 2022. During the year ended June 30, 2023 the Company recorded an additional deemed dividend of approximately $1.1 million in relation to the B Preferred stock and downward price adjustments to certain warrants. During the nine months ended March 31, 2024 the Company recorded a further deemed dividend of approximately $69,181 in relation to the B Preferred stock and downward price adjustments to certain warrants.</span></p>
	ngtf	Description Of Beneficial Conversion Feature DescriptionOfBeneficialConversionFeature	(i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.11082 per share through March 31, 2024.
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4400000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1100000	usd
	us-gaap	Dividends Stock DividendsStock	69181	usd
CY2024Q1	ngtf	Financing Charges Due To Returnable Warrants Issued FinancingChargesDueToReturnableWarrantsIssued	987060	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Reclassification</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may occasionally make certain reclassifications to prior period amounts to conform with the current year’s presentation. Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td></tr> </table>
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	111863	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	126000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	4845	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	261852	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-28834	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1333271	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1304437	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6117	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163644	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	29725	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	63734	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	48824	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	35842	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
	us-gaap	Inventory Write Down InventoryWriteDown	251010	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5978	usd
CY2024Q1	ngtf	Prepaid Professional Fees PrepaidProfessionalFees	142500	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	38747	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29396	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92726	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	187225	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	234411	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	40779	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	648705	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	563737	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	883116	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2022Q4	ngtf	Convertible Price Per Share ConvertiblePricePerShare	0.2
CY2024Q1	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	100000	usd
	us-gaap	Legal Fees LegalFees	15192	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	5434783	shares
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1086957	shares
	ngtf	Forbearance Agreement Description ForbearanceAgreementDescription	The Company shall pay to each Purchaser in cash the sum of $482,250.00 for the full and complete satisfaction of the Notes, which includes all due and owing principal, interest and penalties notwithstanding anything to the contrary in the Notes, as follows: (i) $250,000.00 on or before February 7, 2023; (ii) $50,000.00 on or before February 28, 2023; (iii) $50,000.00 on or before March 31, 2023; (iv) $50,000.00 on or before April 30, 2023; and (v) $82,250.00 on or before May 31, 2023.
	ngtf	Schedule Of Exchange Of Returnable Warrants For Shares Of Common Stock ScheduleOfExchangeOfReturnableWarrantsForSharesOfCommonStock	<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Below is a reconciliation of the extinguishment of debt relative to the exchange of Returnable Warrants for shares of common stock by the holders:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">3,800,000 shares of common stock issued and exchanged for 10,869,566 returnable warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">342,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss on conversion price change in December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,051,801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,988,402</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financing charges due to returnable warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987,060</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Principal increased due to penalty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss on extinguishment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">392,459</td><td style="text-align: left"> </td></tr> </table>
CY2024Q1	ngtf	Shares Of Common Stock Issued Returnable Warrants SharesOfCommonStockIssuedReturnableWarrants	3800000	shares
	ngtf	Under Forbearance Agreement UnderForbearanceAgreement	58703	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	392459	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	960197	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	19251	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	58703	usd
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	19251	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	1018900	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	604800	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49995	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	33907	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	7000000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	57000	shares
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	169941	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	170000	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	30000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2023Q4	us-gaap	Short Duration Contracts Discounted Liabilities Amount ShortDurationContractsDiscountedLiabilitiesAmount	9300	usd
CY2023Q4	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.033
CY2023Q4	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	750	usd
CY2023Q4	ngtf	Outstanding Principal Amount Percentage OutstandingPrincipalAmountPercentage	0.50	pure
CY2023Q4	ngtf	Repayment Repayment	1.50	pure
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2023Q4	ngtf	Discount Issue DiscountIssue	9300	usd
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	170588	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	145000	usd
CY2023Q4	ngtf	Discount Issue DiscountIssue	25588	usd
CY2023Q4	ngtf	Cash Fee CashFee	14500	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	439394	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	388300	usd
CY2024Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	330055	usd
CY2024Q1	ngtf	Discount Issue DiscountIssue	58245	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	336000	usd
CY2024Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	285600	usd
CY2024Q1	ngtf	Discount Issue DiscountIssue	50400	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	55250	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	9750	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	600000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	ngtf	Common Stock As Commitment Shares CommonStockAsCommitmentShares	1477272	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	650000	shares
	ngtf	Cash Fee CashFee	5100	usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	650000	shares
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2024Q1	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	65000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	234411	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	40779	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03333
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	ngtf	Outstanding Share In Percentage OutstandingShareInPercentage	0.50	pure
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5000000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	300000	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	467950	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.5
CY2023Q1	us-gaap	Common Unit Issued CommonUnitIssued	1871800	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000	shares
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	0	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	335	shares
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	335000	usd
CY2024Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5000	shares
	ngtf	Transaction Amount TransactionAmount	4431387	usd
CY2023	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	1136946	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	12870000	shares
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	276066	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	377560	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	650000	shares
CY2023Q3	ngtf	Additional Financing Costs In Cumulative Amount AdditionalFinancingCostsInCumulativeAmount	699350	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28557967	shares
	ngtf	Stock Purchase Warrants StockPurchaseWarrants	1818182	shares
	ngtf	Warrant Description WarrantDescription	Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. The result of the warrant exercise price downward adjustment on modification date is treated as a deemed dividend and fully amortized on the transaction date. In addition to the reduction in exercise price, with certain warrants there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	7390000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4220000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	dei	Security Exchange Name SecurityExchangeName	NONE
CY2023Q2	ngtf	Acquisition Costs Secured By Promissory Note AcquisitionCostsSecuredByPromissoryNote		usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2024Q1	ngtf	Interest Expense Financing Cost InterestExpenseFinancingCost		usd
CY2024Q1	ngtf	Cash Performance Rate CashPerformanceRate	0.02	pure
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
	ngtf	Average Closing Priced Trading Day AverageClosingPricedTradingDay	10	pure
CY2024Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	234747	usd
CY2023Q2	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	101876	usd
CY2024Q1	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	40000	usd
CY2024Q1	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	75250	usd
CY2023Q1	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	37625	usd
	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	149875	usd
	ngtf	Services Fees Related Parties ServicesFeesRelatedParties	112875	usd
CY2024Q1	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	500000	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
	ngtf	Percentage Of Cash Bonus PercentageOfCashBonus	0.10	pure
	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	0.033
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1750	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98556215	shares
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022Q3	ngtf	Stock Issued During Period Value Common Stock From Conversion StockIssuedDuringPeriodValueCommonStockFromConversion		usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022Q4	ngtf	Stock Issued During Period Value Common Stock From Conversion StockIssuedDuringPeriodValueCommonStockFromConversion		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2023Q1	ngtf	Stock Issued During Period Value Common Stock From Conversion StockIssuedDuringPeriodValueCommonStockFromConversion		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments		usd
	ngtf	Financing Cost Due To Default FinancingCostDueToDefault		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	ngtf	Acquisition Costs Secured By Promissory Notes AcquisitionCostsSecuredByPromissoryNotes		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	ngtf	Preferred Stock C Issued Per Acquisition PreferredStockCIssuedPerAcquisition		usd
	ngtf	Preferred Stock A Valuation Per Acquisition PreferredStockAValuationPerAcquisition		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	ngtf	Principal Increased Under Convertible Note Amended PrincipalIncreasedUnderConvertibleNoteAmended		usd
	ngtf	Granted Interest Increased Under Convertible Note Amended GrantedInterestIncreasedUnderConvertibleNoteAmended		usd
	ngtf	Acquisition Cost Under Promissory Note Acquired Under Business Acquisition AcquisitionCostUnderPromissoryNoteAcquiredUnderBusinessAcquisition		usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q2	ngtf	Prepaid Professional Fees PrepaidProfessionalFees		usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2024Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2024Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred		usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001593001

Files In Submission

Name	View Source	Status
0001213900-24-053334-index-headers.html	Edgar Link	pending
0001213900-24-053334-index.html	Edgar Link	pending
0001213900-24-053334.txt	Edgar Link	pending
0001213900-24-053334-xbrl.zip	Edgar Link	pending
ea0207699-10q_nightfood.htm	Edgar Link	pending
ea020769901ex31-1_nightfood.htm	Edgar Link	pending
ea020769901ex32-1_nightfood.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ngtf-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ngtf-20240331_cal.xml	Edgar Link	unprocessable
ngtf-20240331_def.xml	Edgar Link	unprocessable
ngtf-20240331_lab.xml	Edgar Link	unprocessable
ngtf-20240331_pre.xml	Edgar Link	unprocessable
ea0207699-10q_nightfood_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NGTF
NightFood Holdings, Inc. Stock $ngtf

2024 Q2 Form 10-Q Financial Statement

#000121390024053334 Filed on June 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF NightFood Holdings, Inc. Stock $ngtf

2024 Q2 Form 10-Q Financial Statement

#000121390024053334 Filed on June 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF
NightFood Holdings, Inc. Stock $ngtf